INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,623 Cr | ₹1,394 Cr | ₹1,133 Cr | ₹1,794 Cr | ₹1,749 Cr |
What is the latest Total Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹1,623 Cr |
| Mar2025 | ₹1,394 Cr |
| Mar2024 | ₹1,133 Cr |
| Mar2023 | ₹1,794 Cr |
| Mar2022 | ₹1,749 Cr |
How is Total Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,623 Cr | 16.45 | |
| Mar2025 | ₹1,394 Cr | 22.98 | |
| Mar2024 | ₹1,133 Cr | -36.84 | |
| Mar2023 | ₹1,794 Cr | 2.59 | |
| Mar2022 | ₹1,749 Cr | - | |
Compare Total Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,897.8 Cr | -3.4% | -9.3% | 227% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -3.4% |
-9.3% |
227% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses